Personality dimensions and psychopathological profiles of Ecstasy users

被引:49
作者
Dughiero, G
Schifano, F
Forza, G
机构
[1] Addict Treatment Unit 1, Local Hlth Unit 16, Padua, Italy
[2] Univ London St Georges Hosp, Sch Med, Dept Addict Behav & Psychol Med, London SW17 0RE, England
关键词
MDMA; Ecstasy; SCL-90; TPQ; drug prevention;
D O I
10.1002/hup.346
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Only limited information is available with respect to personality traits and the psychopathological characteristics of Ecstasy users. To shed some light on the issue, we compared a group of 43 Ecstasy consumers (made up of both 'experimenters', those who took less than or equal to 27.5 tablets in their lifetime, and 'abusers', those who took larger amounts of the drug) with a composite control group of 77 subjects (made up of drug-free people, cannabis users and users of illicit drugs other than Ecstasy). Three instruments were used: the Questionnaire for the Assessment of the Use of Entactogenic Drugs (to assess modalities and characteristics of Ecstasy use); the Cloninger Tridimensional Personality Questionnaire (which measures harm avoidance, reward dependence and novelty seeking) and the SCL-90 (which measures 10 different psychiatric variables). The Ecstasy consumer group subjects showed higher novelty seeking scores than the controls (p < 0.001), and Ecstasy experimenters showed lower harm avoidance scores than the abusers (p = 0.029), but values of both reward dependence and harm avoidance dimensions were associated with sex. On the SCL-90, Ecstasy users showed higher scores than the controls on the obsession-compulsion (p = 0.004), phobic anxiety (p = 0.037), psychoticism (p = 0.005) and sleep disturbances (p = 0.046) subscales. However, many of the SCL-90 subscale results were associated with sex, and only the psychoticism values seemed to suggest a clinical condition. The main finding of this study is that high novelty seeking scores are characteristic of Ecstasy consumers: The propensity to look selectively for novelties could possibly act as a predisposing factor for Ecstasy abuse itself. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:635 / 639
页数:5
相关论文
共 11 条
  • [1] Cloninger C.R., 1987, TRIDIMENSIONAL PERSO
  • [2] CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/pr0.1991.69.3.1047
  • [3] DEROGATIS LR, 1977, SCL 90 SCORING MANUA
  • [4] LONGITUDINAL EVALUATION OF PSYCHOLOGICAL DISTRESS IN MEDICAL GERIATRIC INPATIENTS
    MAGNI, G
    SCHIFANO, F
    BAIOCCHI, A
    RENESTO, V
    [J]. BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, 1988, 61 : 369 - 375
  • [5] (±)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity:: Clinical studies
    McCann, UD
    Eligulashvili, V
    Ricaurte, GA
    [J]. NEUROPSYCHOBIOLOGY, 2000, 42 (01) : 11 - 16
  • [6] Milani R., 2000, Journal of Psychopharmacology, V14, pA15
  • [7] MINICUCI N, 1998, P NAT C SOC IT TOSS
  • [8] Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users
    Parrott, AC
    Sisk, E
    Turner, JJD
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (01) : 105 - 110
  • [9] SANTI M, 1997, BOLL FARMACODIP ALCO, V20, P39
  • [10] MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients
    Schifano, F
    Di Furia, L
    Forza, C
    Minicuci, N
    Bricolo, R
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1998, 52 (01) : 85 - 90